Monday, September 15, 2025

Latest

Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising results of the company’s proprietary BMB-101 drug to treat a rare form of epilepsy, Dravet Syndrome. The chief officer also talks about the firm’s plan to list on the Nasdaq, the common misconceptions on psychedelics, and the overall outlook of the biotech company in the medical space.

Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs.


FULL DISCLOSURE: Bright Minds Biosciences is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Bright Minds Biosciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

JR Rahn: Using LSD To Treat Mental Health – The Daily Dive

For our Saturday edition of The Daily Dive, host Cassandra Leah sits down with that...

Saturday, March 20, 2021, 01:30:00 PM

Why This “Unknown Metal” Is Suddenly Essential For Defense & Tech | Antimony Resources

In this interview, James Atkinson, CEO of Antimony Resources Corp. (TSXV: ATMY), discusses the current...
Friday, June 27, 2025, 02:18:10 PM

What Will Be China’s Impact On Uranium Markets? – The Daily Dive

Coming back to the Daily Dive is Joe Kelly, CEO of Uranium Markets. He joins...

Friday, January 21, 2022, 01:30:00 PM

Gold To $2500 By Mid-2021? – The Daily Dive feat Tom Meredith

The Daily Dive today is featuring that of Tom Meredith, Executive Chairman of West Red...

Wednesday, November 11, 2020, 01:09:17 PM

There’s Too Much Happening In Lithium Right Now — With John-Mark Staude

Joining us today on the Daily Dive is John-Mark Staude, President, CEO, and Director of...

Friday, February 17, 2023, 01:30:00 PM